A comparative analysis from the ENGULF trial demonstrated that using blood return during continuous aspiration thrombectomy ...
A secondary analysis of the PROMISE III trial has shown that in patients with chronic limb-threatening ischemia (CLTI) who ...
Commencement of activities in international markets is supported by the successful completion of the Limited Market Release, followed by the Recent Full Market Release in the U.S. Strong physician int ...
VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a developer of minimally invasive, non-thermal, non-tumescent ("NT-NT") solutions for venous disease, is pleased to announce the publication of ...
Hjarta Care announced that the FDA has granted de novo authorization for the EVAR XplantR, which is a purpose-built, ...
Microbot Medical designed its Liberty disposable surgical robotic system to overcome adoption barriers in robot-assisted ...
Guerbet, a global leader in medical imaging, announces a positive outcome from a worksharing procedure, involving ...
Zacks Investment Research on MSN
Stereotaxis stock up on first US MAGIC procedures post approval
Stereotaxis STXS has announced the first successful U.S. procedures using its MAGiC robotic magnetic ablation catheter, ...
Sentante co-founder and CEO Edvardas Satkauskas explains what's special about his startup’s remote endovascular robotics ...
Novel bioresorbable scaffold demonstrates primary patency rate of 97% at 3 years, indicative of long-term efficacy -- Achieved 1% post-procedural residual stenosis rate -- lowest rate ever reported in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results